José Manuel Rojas Díaz is working on addressing the high mortality rate of cervical cancer in Mexican women by developing a novel technology called BiKE (bispecific killer cell engager). This technology is designed to target a specific tumour marker, recruiting and stimulating immune cells (NK cells) to enhance the antitumour response against cervical cancer cells, offering a promising therapeutic strategy for improving patient outcomes.
Falling Walls
Falling Walls Science Summit 2023
Login or Register
You need to be logged in to use this feature.
Breaking the Wall of Cervical Cancer
José Manuel Rojas Díaz obtained his Bachelor’s degree in pharmaceutical chemistry and biology and is now a PhD candidate in biomedical sciences with an orientation in immunology at the University of Guadalajara. He is interested in research projects focused on cancer biology, antitumor immune response, and immunotherapies. José Manuel is a Professor at the Technological University of Jalisco with courses in pharmacology and human physiology. He is currently working on the development of a new immunotherapy targeting cervical cancer using a bispecific killer cell engager to boost the innate immune system.
Further Activities to have a look at